Business

November 7, 2013

Salix acquiring San Diego pharmaceutical company for $2.6 billion

Salix Pharmaceuticals announced late Thursday that it is acquiring Santarus, a San Diego-based speciality pharmaceutical company for $2.6 billion.

Related content

Comments

Editor's Choice Videos